RICHMAN ERIC I 4
4 · Gain Therapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
RICHMAN ERIC I
Director
Transactions
- Purchase
Common stock
2022-05-19$2.71/sh+4,000$10,840→ 205,991 total - Purchase
Common Stock
2022-05-20$2.83/sh+9,256$26,194→ 215,247 total
Holdings
- 14,829(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownershipof the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.